

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 5.58673337 |
| 2 | negative thymic T cell selection (GO:0045060) | 5.35758635 |
| 3 | positive T cell selection (GO:0043368) | 4.96342570 |
| 4 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.80606043 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.75583596 |
| 6 | presynaptic membrane assembly (GO:0097105) | 4.65146776 |
| 7 | cellular response to interleukin-15 (GO:0071350) | 4.64782198 |
| 8 | gamma-aminobutyric acid transport (GO:0015812) | 4.56137786 |
| 9 | nucleobase catabolic process (GO:0046113) | 4.45292347 |
| 10 | inositol phosphate catabolic process (GO:0071545) | 4.30335999 |
| 11 | postsynaptic membrane organization (GO:0001941) | 4.30237244 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22748700 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.15581782 |
| 14 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.15155556 |
| 15 | inositol phosphate dephosphorylation (GO:0046855) | 4.15155556 |
| 16 | T cell selection (GO:0045058) | 4.06776446 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.02147615 |
| 18 | response to interleukin-15 (GO:0070672) | 4.01297456 |
| 19 | thymic T cell selection (GO:0045061) | 3.88367560 |
| 20 | T cell receptor signaling pathway (GO:0050852) | 3.87175200 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 3.82547838 |
| 22 | interferon-gamma production (GO:0032609) | 3.75429945 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.71608897 |
| 24 | behavioral response to nicotine (GO:0035095) | 3.67737826 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 3.67190528 |
| 26 | leukocyte aggregation (GO:0070486) | 3.61656974 |
| 27 | negative regulation of osteoblast proliferation (GO:0033689) | 3.57164882 |
| 28 | retinal cone cell development (GO:0046549) | 3.54856473 |
| 29 | startle response (GO:0001964) | 3.51845796 |
| 30 | viral protein processing (GO:0019082) | 3.50064388 |
| 31 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.48605435 |
| 32 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.48554686 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.48227970 |
| 34 | activated T cell proliferation (GO:0050798) | 3.39788185 |
| 35 | neural tube formation (GO:0001841) | 3.39687158 |
| 36 | nonmotile primary cilium assembly (GO:0035058) | 3.39625461 |
| 37 | positive regulation of mitochondrial fission (GO:0090141) | 3.38641310 |
| 38 | lymphocyte costimulation (GO:0031294) | 3.36166284 |
| 39 | intraciliary transport (GO:0042073) | 3.35824925 |
| 40 | T cell costimulation (GO:0031295) | 3.34555453 |
| 41 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.34530814 |
| 42 | protein polyglutamylation (GO:0018095) | 3.33770019 |
| 43 | positive regulation of protein homodimerization activity (GO:0090073) | 3.33030551 |
| 44 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.25249641 |
| 45 | positive regulation of amino acid transport (GO:0051957) | 3.22125507 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.19412767 |
| 47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.18742457 |
| 48 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.18236442 |
| 49 | establishment of mitochondrion localization (GO:0051654) | 3.17446633 |
| 50 | tolerance induction (GO:0002507) | 3.16438257 |
| 51 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.15524690 |
| 52 | sequestering of actin monomers (GO:0042989) | 3.14099415 |
| 53 | epithelial cilium movement (GO:0003351) | 3.13951146 |
| 54 | regulation of gamma-delta T cell activation (GO:0046643) | 3.11309677 |
| 55 | negative regulation of cell killing (GO:0031342) | 3.10134650 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10134650 |
| 57 | negative regulation of telomere maintenance (GO:0032205) | 3.08471488 |
| 58 | regulation of respiratory system process (GO:0044065) | 3.07923631 |
| 59 | forebrain neuron differentiation (GO:0021879) | 3.06146188 |
| 60 | L-fucose catabolic process (GO:0042355) | 3.04094824 |
| 61 | fucose catabolic process (GO:0019317) | 3.04094824 |
| 62 | L-fucose metabolic process (GO:0042354) | 3.04094824 |
| 63 | mechanosensory behavior (GO:0007638) | 3.02991535 |
| 64 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.02900842 |
| 65 | T cell differentiation (GO:0030217) | 3.02844707 |
| 66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.02800048 |
| 67 | DNA deamination (GO:0045006) | 3.02049505 |
| 68 | regulation of cilium movement (GO:0003352) | 3.00846940 |
| 69 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.00459519 |
| 70 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.00094267 |
| 71 | cell differentiation involved in metanephros development (GO:0072202) | 2.99883754 |
| 72 | glycosphingolipid biosynthetic process (GO:0006688) | 2.99158202 |
| 73 | cilium morphogenesis (GO:0060271) | 2.98608786 |
| 74 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.98583485 |
| 75 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.98116929 |
| 76 | regulation of defense response to virus by virus (GO:0050690) | 2.97474615 |
| 77 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.95312473 |
| 78 | regulation of regulatory T cell differentiation (GO:0045589) | 2.94775747 |
| 79 | T cell migration (GO:0072678) | 2.94038644 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93298521 |
| 81 | axonal fasciculation (GO:0007413) | 2.92804707 |
| 82 | lymphoid progenitor cell differentiation (GO:0002320) | 2.92637848 |
| 83 | regulation of pigment cell differentiation (GO:0050932) | 2.91338621 |
| 84 | regulation of development, heterochronic (GO:0040034) | 2.90538263 |
| 85 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90459284 |
| 86 | kidney morphogenesis (GO:0060993) | 2.89571289 |
| 87 | alpha-beta T cell differentiation (GO:0046632) | 2.89432764 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 2.88891790 |
| 89 | synaptic transmission, glutamatergic (GO:0035249) | 2.88791334 |
| 90 | neuronal action potential propagation (GO:0019227) | 2.87021964 |
| 91 | dendritic spine morphogenesis (GO:0060997) | 2.86104102 |
| 92 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84767451 |
| 93 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.83772572 |
| 94 | axoneme assembly (GO:0035082) | 2.83075660 |
| 95 | T cell homeostasis (GO:0043029) | 2.82378082 |
| 96 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.81725940 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81195431 |
| 98 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79376008 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.78537207 |
| 100 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.78382072 |
| 101 | positive regulation of granulocyte differentiation (GO:0030854) | 2.77910515 |
| 102 | regulation of action potential (GO:0098900) | 2.76948883 |
| 103 | synapse assembly (GO:0007416) | 2.76865375 |
| 104 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.74810224 |
| 105 | retinal ganglion cell axon guidance (GO:0031290) | 2.74680052 |
| 106 | developmental pigmentation (GO:0048066) | 2.74362506 |
| 107 | T cell lineage commitment (GO:0002360) | 2.73739213 |
| 108 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.73044585 |
| 109 | T-helper cell differentiation (GO:0042093) | 2.73044585 |
| 110 | cilium organization (GO:0044782) | 2.72031256 |
| 111 | histone H2A acetylation (GO:0043968) | 2.71945121 |
| 112 | cilium assembly (GO:0042384) | 2.69354329 |
| 113 | protein-cofactor linkage (GO:0018065) | 2.69050429 |
| 114 | regulation of telomere maintenance (GO:0032204) | 2.68993578 |
| 115 | serotonin receptor signaling pathway (GO:0007210) | 2.68562833 |
| 116 | negative regulation of mast cell activation (GO:0033004) | 2.67945215 |
| 117 | regulation of timing of cell differentiation (GO:0048505) | 2.67327077 |
| 118 | glutamate receptor signaling pathway (GO:0007215) | 2.65913211 |
| 119 | protein localization to cilium (GO:0061512) | 2.65737563 |
| 120 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.65706464 |
| 121 | neuronal action potential (GO:0019228) | 2.65418468 |
| 122 | positive regulation of synapse assembly (GO:0051965) | 2.63597479 |
| 123 | V(D)J recombination (GO:0033151) | 2.63158786 |
| 124 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62582775 |
| 125 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.62543204 |
| 126 | photoreceptor cell development (GO:0042461) | 2.62284315 |
| 127 | protein localization to synapse (GO:0035418) | 2.62221517 |
| 128 | viral genome replication (GO:0019079) | 2.60963919 |
| 129 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.60722643 |
| 130 | regulation of isotype switching (GO:0045191) | 2.59608093 |
| 131 | olfactory bulb development (GO:0021772) | 2.59148413 |
| 132 | alpha-beta T cell activation (GO:0046631) | 2.58704991 |
| 133 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.58413395 |
| 134 | behavioral response to ethanol (GO:0048149) | 2.57901274 |
| 135 | regulation of respiratory gaseous exchange (GO:0043576) | 2.57840418 |
| 136 | generation of neurons (GO:0048699) | 2.56365065 |
| 137 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.55991159 |
| 138 | positive regulation of tolerance induction (GO:0002645) | 2.55447821 |
| 139 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.53268412 |
| 140 | indolalkylamine metabolic process (GO:0006586) | 2.52841045 |
| 141 | neuron recognition (GO:0008038) | 2.52340298 |
| 142 | regulation of neurotransmitter uptake (GO:0051580) | 2.52232491 |
| 143 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.52181943 |
| 144 | neuron fate determination (GO:0048664) | 2.51869593 |
| 145 | DNA integration (GO:0015074) | 2.50448438 |
| 146 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.50214172 |
| 147 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.50144659 |
| 148 | negative regulation of sodium ion transport (GO:0010766) | 2.49831727 |
| 149 | ketone body metabolic process (GO:1902224) | 2.49645135 |
| 150 | opioid receptor signaling pathway (GO:0038003) | 2.49517935 |
| 151 | DNA double-strand break processing (GO:0000729) | 2.48833532 |
| 152 | dentate gyrus development (GO:0021542) | 2.47588513 |
| 153 | regulation of RIG-I signaling pathway (GO:0039535) | 2.47001367 |
| 154 | neuron-neuron synaptic transmission (GO:0007270) | 2.46765515 |
| 155 | cornea development in camera-type eye (GO:0061303) | 2.45791793 |
| 156 | regulation of protein homodimerization activity (GO:0043496) | 2.45469734 |
| 157 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.44512713 |
| 158 | detection of light stimulus involved in visual perception (GO:0050908) | 2.44512713 |
| 159 | positive regulation of DNA recombination (GO:0045911) | 2.44182458 |
| 160 | neurotransmitter secretion (GO:0007269) | 2.43710803 |
| 161 | negative regulation of protein localization to cell surface (GO:2000009) | 2.43703554 |
| 162 | synaptic vesicle exocytosis (GO:0016079) | 2.43700797 |
| 163 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.43456894 |
| 164 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.43295236 |
| 165 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.42988597 |
| 166 | vocalization behavior (GO:0071625) | 2.42977041 |
| 167 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.42957117 |
| 168 | retinal rod cell development (GO:0046548) | 2.42824665 |
| 169 | eye photoreceptor cell development (GO:0042462) | 2.41826053 |
| 170 | somite development (GO:0061053) | 2.41362510 |
| 171 | transmission of nerve impulse (GO:0019226) | 2.38212049 |
| 172 | auditory behavior (GO:0031223) | 2.37832312 |
| 173 | hindbrain development (GO:0030902) | 2.36054630 |
| 174 | prenylation (GO:0097354) | 2.35745890 |
| 175 | protein prenylation (GO:0018342) | 2.35745890 |
| 176 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.34475115 |
| 177 | DNA demethylation (GO:0080111) | 2.34361032 |
| 178 | cilium movement (GO:0003341) | 2.34278823 |
| 179 | regulation of glucokinase activity (GO:0033131) | 2.34101885 |
| 180 | regulation of hexokinase activity (GO:1903299) | 2.34101885 |
| 181 | positive regulation of mRNA processing (GO:0050685) | 2.32986079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.93898300 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.87577481 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.85605561 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.35075330 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84320692 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.81049409 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.77946308 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.67323360 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.56315398 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.40732758 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.20695491 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.19773646 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19644907 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19193449 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.17748175 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09911825 |
| 17 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01596654 |
| 18 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.00597491 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95163528 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 1.92377775 |
| 21 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.88561271 |
| 22 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.86213014 |
| 23 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85290150 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82798734 |
| 25 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82179513 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82126408 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81945525 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80890592 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.80132241 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79907564 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78489715 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75782195 |
| 33 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.73014974 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72658905 |
| 35 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.70383150 |
| 36 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69813738 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.68871546 |
| 38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.67511824 |
| 39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.67004176 |
| 40 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64636115 |
| 41 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.63930276 |
| 42 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.63877942 |
| 43 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62212704 |
| 44 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62212704 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.60732671 |
| 46 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54899014 |
| 47 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.53522926 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52698891 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52196873 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52196873 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52111299 |
| 52 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51398941 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51061334 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50477578 |
| 55 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.49373873 |
| 56 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.48320613 |
| 57 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46348085 |
| 58 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.45481197 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.44852858 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44459065 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44100466 |
| 62 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.43871445 |
| 63 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43843041 |
| 64 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43447949 |
| 65 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.43162655 |
| 66 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.43138510 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42417398 |
| 68 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41959500 |
| 69 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.40457151 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40308216 |
| 71 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40060698 |
| 72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39792085 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39016962 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38954613 |
| 75 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.37087119 |
| 76 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.37039159 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36113037 |
| 78 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.34961310 |
| 79 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.34531507 |
| 80 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33814689 |
| 81 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32890328 |
| 82 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.32389053 |
| 83 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.31620403 |
| 84 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.30713417 |
| 85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30120096 |
| 86 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.30092453 |
| 87 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.29947541 |
| 88 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.29035885 |
| 89 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27195140 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.26114253 |
| 91 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25807969 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23484491 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23484491 |
| 94 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.23324437 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23088241 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22406223 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22208587 |
| 98 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21607249 |
| 99 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.20167258 |
| 100 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.20023688 |
| 101 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.19723267 |
| 102 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19469483 |
| 103 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.18328006 |
| 104 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18291775 |
| 105 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.17401807 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15777304 |
| 107 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.15501821 |
| 108 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15449343 |
| 109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14206507 |
| 110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12783051 |
| 111 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12714819 |
| 112 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.12568610 |
| 113 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.11362985 |
| 114 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10609086 |
| 115 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10141071 |
| 116 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09118768 |
| 117 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09076375 |
| 118 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09076375 |
| 119 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08627426 |
| 120 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.08438736 |
| 121 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08299525 |
| 122 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07078162 |
| 123 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.06964306 |
| 124 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06809530 |
| 125 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06417313 |
| 126 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06048394 |
| 127 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05833393 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05137921 |
| 129 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.04888576 |
| 130 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04816125 |
| 131 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.02515705 |
| 132 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02506615 |
| 133 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01241426 |
| 134 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00745048 |
| 135 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98975560 |
| 136 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98833835 |
| 137 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98146162 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97354537 |
| 139 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.95075341 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95019901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.69546222 |
| 2 | MP0003880_abnormal_central_pattern | 3.20652399 |
| 3 | MP0005671_abnormal_response_to | 3.02944693 |
| 4 | MP0003787_abnormal_imprinting | 2.93233786 |
| 5 | MP0005646_abnormal_pituitary_gland | 2.84564694 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 2.68581656 |
| 7 | MP0006292_abnormal_olfactory_placode | 2.63973719 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.37913143 |
| 9 | MP0006276_abnormal_autonomic_nervous | 2.35741995 |
| 10 | MP0010386_abnormal_urinary_bladder | 2.31368975 |
| 11 | MP0001188_hyperpigmentation | 2.22969377 |
| 12 | MP0002102_abnormal_ear_morphology | 2.18380282 |
| 13 | MP0000015_abnormal_ear_pigmentation | 2.16811783 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.16578630 |
| 15 | MP0003879_abnormal_hair_cell | 2.04712853 |
| 16 | MP0004381_abnormal_hair_follicle | 2.04286660 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 2.02480841 |
| 18 | MP0000372_irregular_coat_pigmentation | 1.90876314 |
| 19 | MP0005360_urolithiasis | 1.84419217 |
| 20 | MP0001486_abnormal_startle_reflex | 1.82609871 |
| 21 | MP0003011_delayed_dark_adaptation | 1.79231810 |
| 22 | MP0004885_abnormal_endolymph | 1.78136835 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.76464204 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 1.75303486 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 1.74384150 |
| 26 | MP0005409_darkened_coat_color | 1.73628964 |
| 27 | MP0002163_abnormal_gland_morphology | 1.71274171 |
| 28 | MP0009745_abnormal_behavioral_response | 1.68919295 |
| 29 | MP0001502_abnormal_circadian_rhythm | 1.66778487 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.66167163 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.65292600 |
| 32 | MP0005253_abnormal_eye_physiology | 1.65266363 |
| 33 | MP0001905_abnormal_dopamine_level | 1.64510523 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.64216753 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.63696234 |
| 36 | MP0001984_abnormal_olfaction | 1.62511397 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.61667129 |
| 38 | MP0002933_joint_inflammation | 1.61325540 |
| 39 | MP0005394_taste/olfaction_phenotype | 1.59966236 |
| 40 | MP0005499_abnormal_olfactory_system | 1.59966236 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.56574877 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.56355912 |
| 43 | MP0001529_abnormal_vocalization | 1.55173664 |
| 44 | MP0003122_maternal_imprinting | 1.53722036 |
| 45 | MP0000566_synostosis | 1.52420489 |
| 46 | MP0005423_abnormal_somatic_nervous | 1.51409675 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.50905713 |
| 48 | MP0002653_abnormal_ependyma_morphology | 1.50256657 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.49456716 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.48170912 |
| 51 | MP0002064_seizures | 1.46656456 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.42142747 |
| 53 | MP0002063_abnormal_learning/memory/cond | 1.42018073 |
| 54 | MP0004133_heterotaxia | 1.41757428 |
| 55 | MP0005379_endocrine/exocrine_gland_phen | 1.40768090 |
| 56 | MP0002736_abnormal_nociception_after | 1.40135930 |
| 57 | MP0009046_muscle_twitch | 1.38038930 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.36977219 |
| 59 | MP0004043_abnormal_pH_regulation | 1.36974416 |
| 60 | MP0000778_abnormal_nervous_system | 1.36476833 |
| 61 | MP0002735_abnormal_chemical_nociception | 1.35479002 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.35098114 |
| 63 | MP0004270_analgesia | 1.34021469 |
| 64 | MP0002184_abnormal_innervation | 1.33732162 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.33245558 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.32511015 |
| 67 | MP0008569_lethality_at_weaning | 1.28156360 |
| 68 | MP0003724_increased_susceptibility_to | 1.27424853 |
| 69 | MP0002272_abnormal_nervous_system | 1.26072039 |
| 70 | MP0002751_abnormal_autonomic_nervous | 1.20634214 |
| 71 | MP0009379_abnormal_foot_pigmentation | 1.19052455 |
| 72 | MP0002009_preneoplasia | 1.19019825 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 1.18504547 |
| 74 | MP0004859_abnormal_synaptic_plasticity | 1.17824523 |
| 75 | MP0000049_abnormal_middle_ear | 1.17514970 |
| 76 | * MP0002398_abnormal_bone_marrow | 1.17157997 |
| 77 | * MP0002420_abnormal_adaptive_immunity | 1.16350612 |
| 78 | MP0005387_immune_system_phenotype | 1.15344539 |
| 79 | MP0001790_abnormal_immune_system | 1.15344539 |
| 80 | * MP0001819_abnormal_immune_cell | 1.13116200 |
| 81 | MP0000569_abnormal_digit_pigmentation | 1.12544589 |
| 82 | MP0001800_abnormal_humoral_immune | 1.11411178 |
| 83 | MP0002909_abnormal_adrenal_gland | 1.10716022 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.10045619 |
| 85 | MP0001501_abnormal_sleep_pattern | 1.09624735 |
| 86 | MP0000678_abnormal_parathyroid_gland | 1.09615732 |
| 87 | MP0004924_abnormal_behavior | 1.09494285 |
| 88 | MP0005386_behavior/neurological_phenoty | 1.09494285 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 1.08013717 |
| 90 | MP0003121_genomic_imprinting | 1.07912736 |
| 91 | MP0004811_abnormal_neuron_physiology | 1.07188536 |
| 92 | MP0002882_abnormal_neuron_morphology | 1.06540515 |
| 93 | MP0003195_calcinosis | 1.06028747 |
| 94 | MP0005171_absent_coat_pigmentation | 1.04936535 |
| 95 | MP0000538_abnormal_urinary_bladder | 1.03809628 |
| 96 | MP0002166_altered_tumor_susceptibility | 1.03362754 |
| 97 | MP0002723_abnormal_immune_serum | 1.03055667 |
| 98 | MP0005000_abnormal_immune_tolerance | 1.03000036 |
| 99 | MP0000955_abnormal_spinal_cord | 1.00397042 |
| 100 | MP0001986_abnormal_taste_sensitivity | 1.00288663 |
| 101 | * MP0000716_abnormal_immune_system | 0.99993388 |
| 102 | MP0002822_catalepsy | 0.99680894 |
| 103 | MP0005187_abnormal_penis_morphology | 0.99535433 |
| 104 | MP0001963_abnormal_hearing_physiology | 0.98799662 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.98425240 |
| 106 | MP0002177_abnormal_outer_ear | 0.98032409 |
| 107 | MP0005174_abnormal_tail_pigmentation | 0.97295761 |
| 108 | MP0000026_abnormal_inner_ear | 0.96639030 |
| 109 | MP0002752_abnormal_somatic_nervous | 0.95728152 |
| 110 | MP0003866_abnormal_defecation | 0.94453056 |
| 111 | MP0001970_abnormal_pain_threshold | 0.93913842 |
| 112 | MP0001873_stomach_inflammation | 0.93080098 |
| 113 | MP0000685_abnormal_immune_system | 0.92986454 |
| 114 | MP0002006_tumorigenesis | 0.89541990 |
| 115 | MP0002928_abnormal_bile_duct | 0.89422314 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.88122919 |
| 117 | MP0008872_abnormal_physiological_respon | 0.88013448 |
| 118 | MP0002066_abnormal_motor_capabilities/c | 0.85207596 |
| 119 | * MP0000689_abnormal_spleen_morphology | 0.83743448 |
| 120 | MP0005408_hypopigmentation | 0.83560717 |
| 121 | * MP0002722_abnormal_immune_system | 0.83477443 |
| 122 | MP0009785_altered_susceptibility_to | 0.83382021 |
| 123 | MP0001835_abnormal_antigen_presentation | 0.82624612 |
| 124 | MP0004142_abnormal_muscle_tone | 0.82099248 |
| 125 | MP0004147_increased_porphyrin_level | 0.81058483 |
| 126 | MP0002452_abnormal_antigen_presenting | 0.80895872 |
| 127 | MP0004742_abnormal_vestibular_system | 0.80571203 |
| 128 | MP0002938_white_spotting | 0.78951262 |
| 129 | MP0001440_abnormal_grooming_behavior | 0.78544510 |
| 130 | MP0002152_abnormal_brain_morphology | 0.75829672 |
| 131 | MP0008058_abnormal_DNA_repair | 0.74790194 |
| 132 | MP0003698_abnormal_male_reproductive | 0.74246266 |
| 133 | MP0008961_abnormal_basal_metabolism | 0.73626800 |
| 134 | MP0002229_neurodegeneration | 0.73127722 |
| 135 | MP0001919_abnormal_reproductive_system | 0.69499645 |
| 136 | MP0005195_abnormal_posterior_eye | 0.68796257 |
| 137 | MP0003890_abnormal_embryonic-extraembry | 0.68150916 |
| 138 | MP0003633_abnormal_nervous_system | 0.67669921 |
| 139 | MP0005389_reproductive_system_phenotype | 0.67238780 |
| 140 | MP0001929_abnormal_gametogenesis | 0.64529883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal hair whorl (HP:0010721) | 4.13928198 |
| 2 | Chronic hepatic failure (HP:0100626) | 4.04042382 |
| 3 | Focal motor seizures (HP:0011153) | 4.00578536 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 3.76512388 |
| 5 | Pancreatic cysts (HP:0001737) | 3.70252798 |
| 6 | Hypothermia (HP:0002045) | 3.67732049 |
| 7 | Febrile seizures (HP:0002373) | 3.53262877 |
| 8 | Protruding tongue (HP:0010808) | 3.47594731 |
| 9 | Polyphagia (HP:0002591) | 3.44315805 |
| 10 | Nephronophthisis (HP:0000090) | 3.24329821 |
| 11 | T lymphocytopenia (HP:0005403) | 3.15677943 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.12343020 |
| 13 | IgG deficiency (HP:0004315) | 3.10542485 |
| 14 | IgM deficiency (HP:0002850) | 2.98821334 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95202742 |
| 16 | Optic nerve coloboma (HP:0000588) | 2.94560713 |
| 17 | Failure to thrive in infancy (HP:0001531) | 2.89936298 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 2.89863042 |
| 19 | Combined immunodeficiency (HP:0005387) | 2.87049571 |
| 20 | Abnormality of the labia minora (HP:0012880) | 2.86615271 |
| 21 | Increased IgM level (HP:0003496) | 2.84567532 |
| 22 | Type I transferrin isoform profile (HP:0003642) | 2.82950011 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 2.79789026 |
| 24 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.79471322 |
| 25 | Epileptic encephalopathy (HP:0200134) | 2.75266010 |
| 26 | Intestinal atresia (HP:0011100) | 2.70714289 |
| 27 | Optic neuritis (HP:0100653) | 2.67540375 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 2.67540375 |
| 29 | Pachygyria (HP:0001302) | 2.65260853 |
| 30 | Genital tract atresia (HP:0001827) | 2.64312029 |
| 31 | Vaginal atresia (HP:0000148) | 2.62335744 |
| 32 | Abnormality of B cell number (HP:0010975) | 2.62297785 |
| 33 | B lymphocytopenia (HP:0010976) | 2.62297785 |
| 34 | Severe visual impairment (HP:0001141) | 2.61786355 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.61086716 |
| 36 | Abnormality of the renal cortex (HP:0011035) | 2.59363918 |
| 37 | Hyperventilation (HP:0002883) | 2.55516132 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.54691461 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.54691461 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 2.54691461 |
| 41 | Abnormal glycosylation (HP:0012345) | 2.54691461 |
| 42 | Thyroid-stimulating hormone excess (HP:0002925) | 2.54552572 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54021358 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54021358 |
| 45 | Congenital stationary night blindness (HP:0007642) | 2.47725246 |
| 46 | Hemiparesis (HP:0001269) | 2.46430935 |
| 47 | Thyroiditis (HP:0100646) | 2.46267973 |
| 48 | 3-Methylglutaconic aciduria (HP:0003535) | 2.45271130 |
| 49 | Abolished electroretinogram (ERG) (HP:0000550) | 2.44310964 |
| 50 | Abnormality of midbrain morphology (HP:0002418) | 2.43954594 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 2.43954594 |
| 52 | Specific learning disability (HP:0001328) | 2.43751274 |
| 53 | Broad foot (HP:0001769) | 2.43056896 |
| 54 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.42758405 |
| 55 | Myositis (HP:0100614) | 2.42721287 |
| 56 | Stomatitis (HP:0010280) | 2.40281332 |
| 57 | Hypsarrhythmia (HP:0002521) | 2.37714492 |
| 58 | Poor coordination (HP:0002370) | 2.37302204 |
| 59 | Methylmalonic acidemia (HP:0002912) | 2.36433478 |
| 60 | Abnormality of the fingertips (HP:0001211) | 2.35378024 |
| 61 | True hermaphroditism (HP:0010459) | 2.34572528 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34284918 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.33863396 |
| 64 | Large eyes (HP:0001090) | 2.32805385 |
| 65 | Gaze-evoked nystagmus (HP:0000640) | 2.31661317 |
| 66 | Type 2 muscle fiber atrophy (HP:0003554) | 2.26575570 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.24537876 |
| 68 | Abnormality of T cells (HP:0002843) | 2.23728407 |
| 69 | Postaxial hand polydactyly (HP:0001162) | 2.22953670 |
| 70 | Cystic liver disease (HP:0006706) | 2.22250021 |
| 71 | Joint swelling (HP:0001386) | 2.20292170 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 2.20176667 |
| 73 | Broad-based gait (HP:0002136) | 2.17719665 |
| 74 | Large for gestational age (HP:0001520) | 2.16276100 |
| 75 | Abnormal eating behavior (HP:0100738) | 2.14496309 |
| 76 | Dialeptic seizures (HP:0011146) | 2.14492606 |
| 77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.12941094 |
| 78 | Sclerocornea (HP:0000647) | 2.12568418 |
| 79 | Growth hormone deficiency (HP:0000824) | 2.10361603 |
| 80 | Drooling (HP:0002307) | 2.10019184 |
| 81 | Genetic anticipation (HP:0003743) | 2.09995588 |
| 82 | Agitation (HP:0000713) | 2.09022101 |
| 83 | Muscle fiber atrophy (HP:0100295) | 2.07685906 |
| 84 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07268198 |
| 85 | Methylmalonic aciduria (HP:0012120) | 2.07261792 |
| 86 | Absent speech (HP:0001344) | 2.05683895 |
| 87 | Attenuation of retinal blood vessels (HP:0007843) | 2.05598304 |
| 88 | Neuroendocrine neoplasm (HP:0100634) | 2.04553443 |
| 89 | Abnormality of the prostate (HP:0008775) | 2.03458863 |
| 90 | Retinal dysplasia (HP:0007973) | 2.02881308 |
| 91 | Hypoplasia of the thymus (HP:0000778) | 2.02458215 |
| 92 | Optic nerve hypoplasia (HP:0000609) | 2.01364899 |
| 93 | Anencephaly (HP:0002323) | 2.01294804 |
| 94 | Colon cancer (HP:0003003) | 2.00856370 |
| 95 | Blue irides (HP:0000635) | 1.99764106 |
| 96 | Meningitis (HP:0001287) | 1.99412811 |
| 97 | Abnormal ciliary motility (HP:0012262) | 1.99293201 |
| 98 | Poor suck (HP:0002033) | 1.98187136 |
| 99 | Gait imbalance (HP:0002141) | 1.98097918 |
| 100 | Focal seizures (HP:0007359) | 1.97716379 |
| 101 | Type II lissencephaly (HP:0007260) | 1.96935378 |
| 102 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.96668906 |
| 103 | Narrow nasal bridge (HP:0000446) | 1.96571082 |
| 104 | Recurrent sinusitis (HP:0011108) | 1.96163934 |
| 105 | Abnormality of incisor morphology (HP:0011063) | 1.94869555 |
| 106 | Fair hair (HP:0002286) | 1.94440012 |
| 107 | Abnormality of eosinophils (HP:0001879) | 1.94414273 |
| 108 | Excessive salivation (HP:0003781) | 1.92819688 |
| 109 | Chronic sinusitis (HP:0011109) | 1.92415656 |
| 110 | Decreased testicular size (HP:0008734) | 1.92207855 |
| 111 | Pendular nystagmus (HP:0012043) | 1.91478564 |
| 112 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90899966 |
| 113 | Autoimmune hemolytic anemia (HP:0001890) | 1.90784443 |
| 114 | Tongue fasciculations (HP:0001308) | 1.90580132 |
| 115 | Generalized hypopigmentation of hair (HP:0011358) | 1.89910665 |
| 116 | Renal cortical cysts (HP:0000803) | 1.88322177 |
| 117 | Recurrent fungal infections (HP:0002841) | 1.88267966 |
| 118 | Postaxial foot polydactyly (HP:0001830) | 1.88168950 |
| 119 | Atonic seizures (HP:0010819) | 1.87729703 |
| 120 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87504629 |
| 121 | Chronic diarrhea (HP:0002028) | 1.85987355 |
| 122 | Sleep apnea (HP:0010535) | 1.82614328 |
| 123 | Pancreatic fibrosis (HP:0100732) | 1.81155751 |
| 124 | Congenital hepatic fibrosis (HP:0002612) | 1.80803300 |
| 125 | Congenital primary aphakia (HP:0007707) | 1.80405111 |
| 126 | Intellectual disability, moderate (HP:0002342) | 1.79658167 |
| 127 | Lissencephaly (HP:0001339) | 1.79429789 |
| 128 | Progressive inability to walk (HP:0002505) | 1.78480341 |
| 129 | Severe muscular hypotonia (HP:0006829) | 1.77194909 |
| 130 | Inability to walk (HP:0002540) | 1.75917993 |
| 131 | Amblyopia (HP:0000646) | 1.75110730 |
| 132 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.74048245 |
| 133 | Prominent nasal bridge (HP:0000426) | 1.74045584 |
| 134 | Agammaglobulinemia (HP:0004432) | 1.73562688 |
| 135 | Lymphopenia (HP:0001888) | 1.73203492 |
| 136 | Pulmonary fibrosis (HP:0002206) | 1.73177746 |
| 137 | Oligodactyly (hands) (HP:0001180) | 1.73000678 |
| 138 | Oligodontia (HP:0000677) | 1.72213204 |
| 139 | Pheochromocytoma (HP:0002666) | 1.71854821 |
| 140 | Limb dystonia (HP:0002451) | 1.71311000 |
| 141 | Myokymia (HP:0002411) | 1.70944513 |
| 142 | Fetal akinesia sequence (HP:0001989) | 1.70550753 |
| 143 | Flat occiput (HP:0005469) | 1.69645206 |
| 144 | Orchitis (HP:0100796) | 1.69553083 |
| 145 | Macroglossia (HP:0000158) | 1.69312835 |
| 146 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69147226 |
| 147 | Absent/shortened dynein arms (HP:0200106) | 1.69147226 |
| 148 | Self-mutilation (HP:0000742) | 1.68348822 |
| 149 | Absence seizures (HP:0002121) | 1.68344116 |
| 150 | Chronic otitis media (HP:0000389) | 1.67661548 |
| 151 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.67619813 |
| 152 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.67300745 |
| 153 | Abnormality of the incisor (HP:0000676) | 1.64852926 |
| 154 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.64583341 |
| 155 | Short foot (HP:0001773) | 1.64508184 |
| 156 | Narrow forehead (HP:0000341) | 1.64468358 |
| 157 | Exotropia (HP:0000577) | 1.64301402 |
| 158 | Spastic tetraplegia (HP:0002510) | 1.64294764 |
| 159 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.63622462 |
| 160 | Dicarboxylic aciduria (HP:0003215) | 1.63622462 |
| 161 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.63334161 |
| 162 | Broad alveolar ridges (HP:0000187) | 1.62799172 |
| 163 | Esotropia (HP:0000565) | 1.62782254 |
| 164 | Alveolar cell carcinoma (HP:0006519) | 1.62215614 |
| 165 | Renal hypoplasia (HP:0000089) | 1.60984187 |
| 166 | Cerebellar dysplasia (HP:0007033) | 1.60913303 |
| 167 | Generalized myoclonic seizures (HP:0002123) | 1.60819703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.91456990 |
| 2 | CASK | 4.75826006 |
| 3 | MAP2K7 | 3.11528662 |
| 4 | FRK | 2.88303508 |
| 5 | MAP4K2 | 2.76507849 |
| 6 | SGK2 | 2.68082438 |
| 7 | YES1 | 2.59044120 |
| 8 | MAP4K1 | 2.57786901 |
| 9 | TNIK | 2.38813259 |
| 10 | BCR | 2.36186440 |
| 11 | SIK3 | 2.26463785 |
| 12 | MARK1 | 2.25355909 |
| 13 | MAP3K12 | 2.14797270 |
| 14 | NLK | 2.10831573 |
| 15 | PINK1 | 2.01721051 |
| 16 | NTRK2 | 1.96508563 |
| 17 | PRPF4B | 1.89362104 |
| 18 | IKBKE | 1.88046899 |
| 19 | SGK494 | 1.79286727 |
| 20 | SGK223 | 1.79286727 |
| 21 | BMPR1B | 1.79012964 |
| 22 | MAPK13 | 1.71870017 |
| 23 | DAPK2 | 1.67529914 |
| 24 | SGK3 | 1.66716496 |
| 25 | ZAP70 | 1.60017167 |
| 26 | ADRBK2 | 1.47202986 |
| 27 | TRIM28 | 1.44137110 |
| 28 | SIK2 | 1.38130692 |
| 29 | DYRK3 | 1.37756421 |
| 30 | ITK | 1.35226317 |
| 31 | MUSK | 1.33995081 |
| 32 | SRPK1 | 1.32056574 |
| 33 | GRK1 | 1.31507649 |
| 34 | KDR | 1.30830621 |
| 35 | AKT3 | 1.29546608 |
| 36 | DAPK1 | 1.25624055 |
| 37 | SYK | 1.24011709 |
| 38 | LIMK1 | 1.23853626 |
| 39 | IRAK4 | 1.23433923 |
| 40 | MKNK2 | 1.21510233 |
| 41 | PNCK | 1.21407087 |
| 42 | EPHA3 | 1.20970960 |
| 43 | PAK3 | 1.20839211 |
| 44 | STK16 | 1.18761902 |
| 45 | TNK2 | 1.16151335 |
| 46 | PRKD3 | 1.13305032 |
| 47 | BCKDK | 1.11913244 |
| 48 | JAK3 | 1.08487429 |
| 49 | UHMK1 | 1.08406921 |
| 50 | CDK19 | 1.07443149 |
| 51 | MINK1 | 1.04021672 |
| 52 | BMPR2 | 1.02899819 |
| 53 | LCK | 1.02584586 |
| 54 | ERBB3 | 1.02209702 |
| 55 | MAP3K14 | 1.01483134 |
| 56 | EPHA4 | 1.01314358 |
| 57 | MAP3K4 | 1.00725941 |
| 58 | INSRR | 1.00689523 |
| 59 | RPS6KA4 | 0.99972546 |
| 60 | DYRK2 | 0.98467686 |
| 61 | FGFR3 | 0.96791433 |
| 62 | PRKCH | 0.95002278 |
| 63 | ACVR1B | 0.94259296 |
| 64 | TEC | 0.93585225 |
| 65 | WNK4 | 0.92102480 |
| 66 | CDK3 | 0.92092900 |
| 67 | IRAK3 | 0.90864391 |
| 68 | PRKCE | 0.90506148 |
| 69 | PHKG2 | 0.89199285 |
| 70 | PHKG1 | 0.89199285 |
| 71 | GRK7 | 0.87945684 |
| 72 | FLT3 | 0.87708879 |
| 73 | HIPK2 | 0.86578947 |
| 74 | CDK8 | 0.86577996 |
| 75 | NTRK3 | 0.83978321 |
| 76 | IRAK2 | 0.82653513 |
| 77 | CCNB1 | 0.81067189 |
| 78 | BLK | 0.79627725 |
| 79 | IRAK1 | 0.78136199 |
| 80 | FGFR4 | 0.74774006 |
| 81 | TGFBR1 | 0.74127219 |
| 82 | CHUK | 0.66624879 |
| 83 | PAK6 | 0.64839997 |
| 84 | TLK1 | 0.63805659 |
| 85 | FES | 0.63472557 |
| 86 | TESK1 | 0.62860820 |
| 87 | JAK1 | 0.62276961 |
| 88 | MAP2K4 | 0.61766937 |
| 89 | PLK2 | 0.61452281 |
| 90 | PRKCQ | 0.60754299 |
| 91 | CAMK4 | 0.59794480 |
| 92 | MKNK1 | 0.59711577 |
| 93 | KIT | 0.58741337 |
| 94 | HCK | 0.58728724 |
| 95 | RPS6KA5 | 0.58653032 |
| 96 | FGFR2 | 0.57175229 |
| 97 | WNK3 | 0.57046892 |
| 98 | BRD4 | 0.56507322 |
| 99 | MAPK4 | 0.56427400 |
| 100 | LYN | 0.53235463 |
| 101 | ADRBK1 | 0.50455384 |
| 102 | MST4 | 0.49925734 |
| 103 | PRKCG | 0.49353171 |
| 104 | BTK | 0.49183696 |
| 105 | NUAK1 | 0.49111319 |
| 106 | CAMKK2 | 0.48149441 |
| 107 | OXSR1 | 0.46827471 |
| 108 | TYK2 | 0.46632974 |
| 109 | MAPK15 | 0.45959885 |
| 110 | SGK1 | 0.44644098 |
| 111 | CDK5 | 0.43989644 |
| 112 | GRK6 | 0.43653943 |
| 113 | DYRK1A | 0.42763834 |
| 114 | PRKG1 | 0.42215239 |
| 115 | PRKCZ | 0.41889554 |
| 116 | PRKACA | 0.41195453 |
| 117 | MARK2 | 0.39666815 |
| 118 | CSNK1G2 | 0.38920465 |
| 119 | TSSK6 | 0.38825360 |
| 120 | CSNK1G1 | 0.38427544 |
| 121 | EIF2AK2 | 0.38089994 |
| 122 | RPS6KB1 | 0.37937576 |
| 123 | CSNK1D | 0.37322337 |
| 124 | CAMK1 | 0.37247621 |
| 125 | VRK1 | 0.37095899 |
| 126 | CSNK1A1 | 0.36568937 |
| 127 | CSF1R | 0.35280536 |
| 128 | CAMK2D | 0.34600570 |
| 129 | ATM | 0.34433032 |
| 130 | TAOK3 | 0.33949909 |
| 131 | CAMK2A | 0.33739483 |
| 132 | CSNK1G3 | 0.32915780 |
| 133 | CSK | 0.32443136 |
| 134 | ZAK | 0.32441031 |
| 135 | PASK | 0.30799706 |
| 136 | STK11 | 0.30479290 |
| 137 | STK39 | 0.30219168 |
| 138 | MAP2K6 | 0.29973122 |
| 139 | DYRK1B | 0.29184298 |
| 140 | PRKACB | 0.28658851 |
| 141 | CDK14 | 0.28628318 |
| 142 | PKN1 | 0.28191320 |
| 143 | IKBKB | 0.27704119 |
| 144 | CSNK1A1L | 0.27643162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.65621992 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.69014377 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.95629558 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.95550496 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.72094091 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.20690052 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20578151 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15166355 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.14923716 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.12785813 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08137216 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.07517139 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04403488 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.00900907 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.94679526 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.90132543 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.89346707 |
| 18 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.80659902 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.75131579 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.71545980 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.71410593 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.70622294 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66969239 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.59331189 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55837345 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.54928181 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54761744 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51851170 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.50154748 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47124127 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.43485417 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.42092947 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41732209 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40917811 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.37255447 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35568512 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.33701831 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.31553549 |
| 39 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.31005571 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.30903974 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30196725 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.26229412 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.21941473 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21905405 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21318436 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.14608528 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05044344 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04746045 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03978050 |
| 50 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.03229907 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02962849 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02005670 |
| 53 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.99710875 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99455196 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96129745 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95651415 |
| 57 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95647134 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93701744 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91932003 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90920266 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90187058 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88886033 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86003279 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.85554433 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85212828 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84295311 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.81191859 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80679707 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80384926 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79631764 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78658887 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78438773 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.78116742 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76939143 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75273765 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73262858 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.72598360 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.72249955 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71896657 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68022569 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66978509 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65337317 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62085094 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61954039 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.61327188 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.60487400 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60257532 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59884291 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59866099 |
| 90 | Spliceosome_Homo sapiens_hsa03040 | 0.59853394 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59444502 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.58291037 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57846632 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57018411 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56849946 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55647448 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55571569 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54834579 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54641535 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53513506 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52282129 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.52213160 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51864099 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.50849923 |
| 105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50527158 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49490142 |
| 107 | Proteasome_Homo sapiens_hsa03050 | 0.49064252 |
| 108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48465284 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.46519948 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46123683 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45209030 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44878792 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44455843 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44160183 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.44006970 |
| 116 | Melanogenesis_Homo sapiens_hsa04916 | 0.43574353 |
| 117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43039326 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41393679 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41372519 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40997304 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40036041 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38361336 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37456677 |
| 124 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37128659 |
| 125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37007947 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36713364 |
| 127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36452552 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34317811 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34260357 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33996264 |
| 131 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33695051 |
| 132 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.33589758 |
| 133 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.33155171 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32687870 |
| 135 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31317630 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30972819 |
| 137 | Prostate cancer_Homo sapiens_hsa05215 | 0.30421443 |
| 138 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30338383 |
| 139 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30323372 |
| 140 | Influenza A_Homo sapiens_hsa05164 | 0.30124958 |
| 141 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.23620933 |

